← Back
$BCAX All transactions

Bicara Therapeutics Inc.

▼ SELL 10b5-1 Plan

$ Value

$4K

Shares

200

Price

$18

Filed

Mar 5

Insider

Name

Raben David

Title

Chief Medical Officer

CIK

0002034679

Roles

Officer

Transaction Details

Transaction Date

2026-03-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

55,286

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.45 to $18.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. | The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

Filing Info

Accession No.

0001628280-26-015419

Form Type

4

Issuer CIK

0002023658

Raben David's History

Date Ticker Type Value
2026-03-25 BCAX M $21K
2026-03-25 BCAX $104K
2026-03-25 BCAX M $0
2026-03-04 BCAX M $62K
2026-03-04 BCAX $302K
2026-03-04 BCAX M $0
2026-03-03 BCAX M $758
2026-03-03 BCAX $4K
2026-03-03 BCAX M $0
2026-02-02 BCAX A $0

Other Insiders at BCAX (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $40.0M 2026-02-26
Meisner Lara
Chief Legal Officer
2026-02-02
Cohlhepp Ryan
President and COO
$984K 2026-04-15
Hyep Ivan
Chief Financial Officer
$717K 2026-04-21
Mazumdar Claire
Chief Executive Officer
$1.5M 2026-04-20
Raben David
Chief Medical Officer
$406K 2026-03-25